Lunes, 08 de Mayo de 2017 10:14

Endpoints NewsMitsubishi's Radicava, first ALS med in decades, beats all comers to ...FiercePharmaThe FDA was so impressed with Mitsubishi Tanabe's amyotrophic lateral sclerosis drug, it recruited the company to file its data for U.S. approval based solely on data generated in Japan. Now, with a Friday approval for Radicava, ALS patients in the U.S ...Mitsubishi Tanabe wins the race to snag the first new ALS drug OK ...Endpoints Newslos 115 artículos informativos »

Toda la noticia: Mitsubishi: Google Noticias

< Prev		Próximo >